Fate Therapeutics, Inc.
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2012 | — | -507.8% | -533.3% |
| FY2013 | — | -1,820.3% | -2,151.8% |
| FY2015 | — | -1,142.8% | -1,233.7% |
| FY2016 | — | -726.1% | -760.2% |
| FY2017 | — | -1,025.9% | -1,046.1% |
| FY2018 | — | -1,415.4% | -1,405.0% |
| FY2019 | — | -943.1% | -919.0% |
| FY2020 | — | -407.5% | -551.6% |
| FY2021 | — | -388.6% | -379.9% |
| FY2022 | — | -320.2% | -292.5% |
| FY2023 | — | -299.9% | -253.3% |
| FY2024 | — | -1,542.6% | -1,366.5% |
| FY2025 | — | -2,222.4% | -2,051.1% |